The TET2 interactors and their links to hematological malignancies

Feng Pan, Ophelia Weeks, Feng Chun Yang, Mingjiang Xu

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Ten-eleven translocation (TET) family proteins are dioxygenases that oxidize 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine in DNA, early steps of active DNA demethylation. TET2, the second member of TET protein family, is frequently mutated in patients with hematological malignancies, leading to aberrant DNA methylation profiling and decreased 5hmC levels. Located in the nucleus and acting as a DNA-modifying enzyme, TET2 is thought to exert its function via TET2-containing protein complexes. Identifying the interactome network of TET2 likely holds the key to uncover the mechanisms by which TET2 exerts its function in cells. Here, we review recent literature on TET2 interactors and discuss their possible roles in TET2 loss-mediated dysregulation of hematopoiesis and pathogenesis of hematological malignancies.

Original languageEnglish (US)
Pages (from-to)438-445
Number of pages8
JournalIUBMB Life
Issue number6
StatePublished - Jun 1 2015
Externally publishedYes


  • human molecular disease
  • molecular genetics
  • protein function
  • proteonomics

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology


Dive into the research topics of 'The TET2 interactors and their links to hematological malignancies'. Together they form a unique fingerprint.

Cite this